Fitoplancton Marino, first company to globally market a microalgae enzyme for healthy aging and sports performance
April 26, 2019. FITOPLANCTON MARINO presents a marine ingredient for Healthy Aging and Sports Nutrition. It will be available at Vitafoods Show (May 7th-9th in Geneva).
TetraSOD®, a unique marine ingredient, is clean label, vegan and sustainably produced. Solid science backs its application as a complete and comprehensive support for Healthy Ageing as well as for Peak Performance and Recovery. TetraSOD® is available through FITOPLANCTON MARINO globally, and recently launched in the U.S. and Canada by LONZA, under the Oceanix™ brand.
On 5th of March 2019 LONZA had announced the launch of its new performance nutrition brand, Oceanix™ in the U.S.A and Canada. The unique phytoplankton ingredient is sustainably sourced from the ocean and meets rising demand for natural, non-GMO and vegan supplement products.
Containing highly active antioxidant enzymes, including superoxide dismutase (SOD), as well as essential fatty acids, vitamins, amino acids and minerals, the TetraSOD® ingredient offers the most complete and comprehensive Healthy Aging nutraceutical solution. In addition TetraSOD® offers but also offers athletes and individuals with active lifestyles potential benefits for physical performance and an increased physiological response against oxidative stress to aid recovery in a small, concentrated dose. TetraSOD® is the most concentrated SOD source in the market, with science backed demonstrated efficiency on activating the antioxidant response pathway on human cells. Further information can be found at www.tetrasod.com.
About Fitoplancton Marino
Fitoplancton Marino is a Marine Biotech Company established in 2002 in South of Spain, focused on satisfying the market needs of various sectors including aquaculture, aquarium keeping, cosmetics, health and nutrition, guaranteeing the best standards in quality.
"Our mission is to Research, Develop and Supply microalgae based products and functional ingredients that contribute to improve the good health and quality of life to our consumers."
In 2011 we joined the Hisparroz Group, linked to the multinational EBRO Foods. The objective for the next decade is to consolidate Fitoplancton Marino as a leader in the production and commercialization of products with high added value derived from microalgae.
Lonza is an integrated solutions provider that creates value along the Healthcare Continuum®. Through their Pharma Biotech & Nutrition segment and their Specialty Ingredients segment businesses, they harness science and technology to serve markets along this continuum. They focus on creating a healthy environment, promoting a healthier lifestyle and preventing illness through consumers' preventive healthcare, as well as improving patient healthcare by supporting their customers to deliver innovative medicines that help treat or even cure severe diseases. Further information can be found at www.lonza.com .
Certain matters discussed in this news release may constitute forward-looking statements. These statements are based on current published information on media. The actual results may differ materially in the future from the forward-looking statements included in this news release due to various factors. Furthermore, except as otherwise required by law, Fitoplancton Marino disclaims any intention or obligation to update the statements contained in this news release.
More information email@example.com